This is a routine insider sale from RSU vesting with no material signal. Monitor for any acceleration in insider selling or changes in pattern, but no immediate trading action warranted.
RVMD drugs
RVMD drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 16 $156.58entry
- T+1 · 5mo ago +0.76%α +2.01% · $157.77
- T+5 · 5mo ago +8.26%α +10.49% · $169.51
- T+20 · 4mo ago +18.13%α +17.93% · $184.97
- T+60 · 2mo ago +29.87%α +28.87% · $203.35
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Officer Margaret A. Horn filed a Form 144 notice of intent to sell 3,486 shares of Revolution Medicines common stock, valued at approximately $536K. This is a routine sale from vested RSU grants and follows prior sales of 14,583 shares over the past three months. The proposed sale is immaterial relative to the company's $32.7B market cap.
Key Facts
- Insider: Margaret A. Horn, an officer of Revolution Medicines
- Proposed sale: 3,486 shares of common stock, estimated value $536,390.82
- Shares acquired from RSU grants on 03/01/2023, 03/01/2024, and 03/01/2025
- Prior sales in past 3 months: 4,583 shares on 03/17/2026 and 10,000 shares on 06/11/2026
- Filing date: June 15, 2026
Financial Impact
Proceeds of ~$536K from sale of 3,486 shares; negligible relative to $32.7B market cap
Risk Factors
- None material from this filing; insider selling pattern is consistent with RSU vesting and tax obligations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001294192-26-000002 |
| Document: 0001294192-26-000002-index.html | 0001294192-26-000002 |
| Document: 0001294192-26-000002.txt | 0001294192-26-000002 |
Track record
44 reports on RVMD
7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $176.02 Now $166.87 −5.20% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $176.35 Now $166.87 −5.38% settles Feb 10
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers